In degenerative joint diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA), loss of PGs especially aggrecan from articular cartilage is regarded as the key initial event in disease onset and development [7] and is considered as a target for intervention that would slow the progression of disease. The gene discussed is ACAN; the disease is osteoarthritis.